简介内容:HCV-IN-41 (compound 4), a potent inhibitor of the hepatitis C virus (HCV), demonstrates exceptional inhibitory effectiveness across different genotypes, with EC 50 values of nM for genotype 1b, nM for 2a, nM for 3a, and nM for 4a, respectively. It effectively reduces HCV RNA replication [1].